Funded by an IRDiRC member =

Research projects

FRANCE

NORMANDIE
ROUEN

Study of genetic factors leading to appearance of pemphigus vulgaris, foliaceous and paraneoplastic

Faculté de médecine et de pharmacie de Rouen

Physiopathologie et biothérapies des maladies inflammatoires et auto-immunes

More details

FRANCE

NORMANDIE
ROUEN

Animal and experimental models of pemphigus vulgaris, foliaceous and paraneoplastic

Faculté de médecine et de pharmacie de Rouen

Physiopathologie et biothérapies des maladies inflammatoires et auto-immunes

More details

GERMANY

Baden-Württemberg
TÜBINGEN

PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Innate immune responses in pemphigus vulgaris (SP3)

Behandlungs- und Forschungszentrum für Seltene Erkrankungen ZSE Tübingen

Zentrum für Seltene Erkrankungen (ZSE) Tübingen

More details

GERMANY

Baden-Württemberg
TÜBINGEN

PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): T-cell-dependent regulation of autoreactive B cells in pemphigus (SP2)

Universitäts-Hautklinik

More details

GERMANY

Bayern
MÜNCHEN

PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Desmoglein-dependent signaling complexes in pemphigus (SP5)

Anatomische Anstalt der LMU München

Anatomische Anstalt - Lehrstuhl I

More details

GERMANY

Hessen
GIEßEN

PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Flotillins in the regulation of desmosomal adhesion in pemphigus (SP4)

Justus-Liebig-Universität Gießen

Institut für Biochemie - AG Prof. Dr. A. Bindereif

More details

GERMANY

Hessen
MARBURG

PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): T-cell-dependent regulation of autoreactive B cells in pemphigus (SP2)

Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg

Allergie-Zentrum Hessen / Klinik für Dermatologie und Allergologie

More details

GERMANY

Hessen
MARBURG

PEGASUS: Pemphigus - from Pathogenesis to Therapeutics (FOR 2497): Human leukocyte antigen (HLA)-transgenic mice as a pre-clinical model of pemphigus vulgaris (SP1)

Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg

Klinik für Dermatologie und Allergologie

More details

GERMANY

Schleswig-Holstein
LÜBECK

Cutaneous complement C3 as key driver of pemphigoid disease pathogenesis (KFO 303: Pemphigoid Diseases - Molecular Pathways and their Therapeutic Potential)

Universitätsklinikum Schleswig-Holstein - Campus Lübeck

Klinik für Dermatologie, Allergologie und Venerologie

More details

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

Engineering disease-specific t cells for pemphigus therapy

Institution: Information not provided - US

More details

Multicentric Research projects

GERMANY
Hessen
MARBURG
PEMPHIGUS: Von der Autoimmunität zur Krankheit
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Dermatologie und Allergologie
More details